Effect of imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno) on immunity in patients with malignant melanoma.
D000577:Amides / Q000494:pharmacology / Q000627:therapeutic use; D000917:Antibody Formation / Q000187:drug effects*; D000942:Antigens, Bacterial; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002722:Chlorobenzenes; D004926:Escherichia coli / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D007111:Immunity, Cellular / Q000187:drug effects*; D007156:Immunologic Memory; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology; D012882:Skin Tests; D013745:Tetanus Toxoid; D014226:Triazenes / Q000494:pharmacology / Q000627:therapeutic use*
D000577:Amides; D000942:Antigens, Bacterial; D000970:Antineoplastic Agents; D002722:Chlorobenzenes; D007093:Imidazoles; D013745:Tetanus Toxoid; D014226:Triazenes